Clinical Trials Browser

Withdrawn × Neoplasm Metastasis × Sorafenib × Clear all

NCT04465734 2022-05-05

A Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCC

Phase 3 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasm Metastasis